The Scientist

» rare diseases and disease/medicine

Most Recent

image: Dengue’s Downfall?

Dengue’s Downfall?

By | September 15, 2015

Researchers characterize a protein that could be key to the virus’s virulence—and to developing a vaccine against the mosquito-borne disease.

0 Comments

image: Traditional Medicine for Leishmaniasis

Traditional Medicine for Leishmaniasis

By | September 14, 2015

A plant used in traditional Mayan remedies to cure the parasitic infection produces a potent compound.

0 Comments

image: Can Amyloid Spread Between Brains?

Can Amyloid Spread Between Brains?

By | September 9, 2015

A study of deceased patients who received injections of cadaver-derived growth hormone hints at the possible transmissibility of Alzheimer’s disease. 

1 Comment

image: <em>Legionella</em> Strikes Again

Legionella Strikes Again

By | September 2, 2015

Following an outbreak in New York City last month, Legionnaires’ disease pops up in Illinois and California. 

0 Comments

image: Body, Heal Thyself

Body, Heal Thyself

By | September 1, 2015

Reviving a decades-old hypothesis of autoimmunity

8 Comments

image: Capsule Reviews

Capsule Reviews

By | September 1, 2015

Brain Storms, Orphan, Maize for the Gods, and Paranoid.

0 Comments

image: Hear and Now

Hear and Now

By | September 1, 2015

Auditory research advances worth shouting about

0 Comments

image: Huh?

Huh?

By | September 1, 2015

Hearing loss can occur for a variety of reasons, and sometimes more than one.

0 Comments

image: Hurdles for Hearing Restoration

Hurdles for Hearing Restoration

By | September 1, 2015

Given the diverse cell types and complex structure of the human inner ear, will researchers ever be able to re-create it?

1 Comment

image: Orchestrating Organoids

Orchestrating Organoids

By | September 1, 2015

A guide to crafting tissues in a dish that reprise in vivo organs

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech